Compugen (CGEN) Cash & Current Investments (2009 - 2026)
Compugen's (CGEN) quarterly Cash & Current Investments came in at $91.8 million in Q1 2026, up 29.13% year-on-year from $71.1 million in Q1 2025, and down 32.71% quarter-over-quarter from $136.4 million in Q4 2025.
Compugen (CGEN) Cash & Current Investments (2009 - 2026) Analysis & Trends
Compugen has disclosed Cash & Current Investments across 18 years of filings, most recently posting $91.8 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $91.8 million, up 29.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $91.8 million (up 29.13% YoY), and the FY2025 annual result was $136.4 million, up 71.25% from the prior year.
- Cash & Current Investments came in at $91.8 million for Q1 2026 at Compugen, down from $136.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $136.4 million in Q4 2025 to a low of $11.1 million in Q4 2022.
- The 5-year median for Cash & Current Investments is $68.0 million (2025), against an average of $70.9 million.
- Across the five-year window, Cash & Current Investments sank 90.55% in 2022 and surged 252.14% in 2023, its largest moves.
- Compugen's Cash & Current Investments stood at $11.1 million in 2022, then soared by 252.14% to $38.9 million in 2023, then soared by 104.47% to $79.6 million in 2024, then jumped by 71.25% to $136.4 million in 2025, then tumbled by 32.71% to $91.8 million in 2026.
- The last three Cash & Current Investments figures came in at $91.8 million (Q1 2026), $136.4 million (Q4 2025), and $59.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 91.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.75 Mn |
| Dec 31, 2025 | 136.36 Mn |
| Sep 30, 2025 | 59.36 Mn |
| Jun 30, 2025 | 65.00 Mn |
| Mar 31, 2025 | 71.06 Mn |
| Dec 31, 2024 | 79.63 Mn |
| Sep 30, 2024 | 79.57 Mn |
| Jun 30, 2024 | 59.32 Mn |
| Dec 31, 2023 | 38.94 Mn |
| Jun 30, 2023 | 61.37 Mn |
| Dec 31, 2022 | 11.06 Mn |
| Jun 30, 2022 | 96.93 Mn |
| Dec 31, 2021 | 117.05 Mn |
| Jun 30, 2021 | 111.09 Mn |
| Dec 31, 2020 | 123.77 Mn |
| Jun 30, 2020 | 136.07 Mn |
| Dec 31, 2019 | 43.23 Mn |
| Jun 30, 2019 | 36.98 Mn |
| Dec 31, 2018 | 45.68 Mn |
| Jun 30, 2018 | 43.09 Mn |